title: Pitfalls in preparation of (3)H-unconjugated bilirubin by biosynthetic labeling from precursor (3)H-5-aminolevulinic acid in the dog.
abstract: We report problems encountered during preparation of tritium-labeled unconjugated bilirubin ((3)H-UCB) from precursor (3)H-5-aminolevulinic acid ((3)H-ALA) in 2 dogs with external biliary drainage installed into the animals under general anesthesia. Under prolonged sedation, 12.9 or 14.0 mCi of (3)H-ALA was administered intravenously in two divided doses, and bile was collected for 9 hours. In one animal, taurocholate (TC) infusion was needed to maintain bile flow. (3)H-UCB was isolated from the bile and recrystallized with the improved method of Webster et al (Webster CC, Tiribelli C, Ostrow JD. J Lab Clin Med 2001;137:370-3). Based on radioactivity and pigment content, hourly bile collections were pooled to optimize specific activities. Surprisingly, in the first dog, only 2.9% of injected radioactivity was recovered in bile and only 14.1% in urine, and the specific activities of the crystalline (3)H-UCB from the two pools were only 39.5 and 30.0 x 10(3) dpm/microg. High-performance liquid chromatography analysis revealed that only 4% of ALA degraded during 5 minutes in injection solution at pH 6.8. The low incorporation of (3)H-ALA and low specific activity of (3)H-UCB was apparently caused mainly by prior degradation and exchange of labile tritium of the (3)H-ALA and probably by enhanced endogenous ALA synthesis caused by the anesthetic/sedative agents. Revised procedures in the second dog improved the incorporation of (3)H-ALA to 11.9% excreted in bile and the specific activity of the crystalline (3)H-UCB to 122.0 and 50.8 x 10(3) dpm/microg, while urinary excretion of tritium increased to 28.5%. These experiences emphasize possible pitfalls in preparing (3)H-UCB by biosynthetic labeling from (3)H-ALA administered to dogs.
authors.affiliation: Department of Physiology, University of León, Spain.
authors.forename: J E
authors.initials: JE
authors.lastname: Bayón
authors.forename: L
authors.initials: L
authors.lastname: Pascolo
authors.forename: J M
authors.initials: JM
authors.lastname: Gonzalo-Orden
authors.forename: J R
authors.initials: JR
authors.lastname: Altonaga
authors.forename: J
authors.initials: J
authors.lastname: González-Gallego
authors.forename: C
authors.initials: C
authors.lastname: Webster
authors.forename: W G
authors.initials: WG
authors.lastname: Haigh
authors.forename: M
authors.initials: M
authors.lastname: Stelzner
authors.forename: C
authors.initials: C
authors.lastname: Pekow
authors.forename: C
authors.initials: C
authors.lastname: Tiribelli
authors.forename: J D
authors.initials: JD
authors.lastname: Ostrow
mesh_terms: D000622:Aminolevulinic Acid / Q000378:metabolism*; D000758:Anesthesia; D000818:Animals; D001646:Bile / Q000378:metabolism; D001663:Bilirubin / Q000096:biosynthesis*; D004285:Dogs; D007553:Isotope Labeling; D008297:Male; D014316:Tritium
chemical_list: D014316:Tritium; D000622:Aminolevulinic Acid; D001663:Bilirubin